Coaxil 12,5 mg obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

coaxil 12,5 mg obložene tablete

servier pharma d.o.o., tuškanova 37, zagreb, hrvatska - tianeptinnatrij - obložena tableta - 12,5 mg - urbroj: jedna tableta sadrži 12,5 mg tianeptinnatrija što odgovara 11,90 mg tianeptina

Neptika 12,5 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

neptika 12,5 mg filmom obložene tablete

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - tianeptinnatrij - filmom obložena tableta - 12,5 mg - urbroj: jedna filmom obložena tableta sadrži 12,5 mg tianeptinnatrija

TIALERA 12.5 mg/1 tableta film tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

tialera 12.5 mg/1 tableta film tableta

zentiva pharma d.o.o. - тианептина - film tableta - 12.5 mg/1 tableta - 1 film tableta sadrži: 12,5 mg tianeptin natrijuma

Sugammadex Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - uklanjanje neuromuskularne blokade izazvane rokoronom ili vekuronomom. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Piramal Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskularna blokada - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Adroiq Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Drovelis Europska Unija - hrvatski - EMA (European Medicines Agency)

drovelis

gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - spolni hormoni i modulatori genitalnog sustava, - oral contraceptive.

Lydisilka Europska Unija - hrvatski - EMA (European Medicines Agency)

lydisilka

estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - spolni hormoni i modulatori genitalnog sustava, - oralna kontracepcija. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.